[1] |
Miller VM, Harman SM. An update on hormone thera-py in postmenopausal women: mini-review for the basic scientist[J]. Am J Physiol Heart Circ Physiol, 2017, 313 (5): H1013-H1021.
|
[2] |
Karaoulanis SE, Rizouli KA, Rizoulis AA, et al. Lack of association of acute phase response proteins with hormone levels and antidepressant medication in perimenopausal depression[J]. BMC Psychiatry, 2014 (14): 164.
|
[3] |
中华人民共和国卫生部. 冠状动脉粥样硬化性心脏病诊断标准[M].北京:中国标准出版社,2010:1-13.
|
[4] |
韩雅玲.中国经皮冠状动脉介入治疗指南2012(简本)[J/CD].中华危重症医学杂志(电子版),2012,5(3):169-180.
|
[5] |
Zhou M, Wang H, Zhu J, et al. Cause-specific morta-lity for 240 causes in China during 1990-2013: a systematic subnational analysis for the Global Burden of Disease Study 2013[J]. Lancet, 2016, 387 (10015): 251-272.
|
[6] |
Gorczyca AM, Eaton CB, LaMonte MJ, et al. Change in physical activity and sitting time after myocardial infarction and mortality among postmenopausal women in the women's Health initiative-observational study[J]. J Am Heart Assoc, 2017, 6 (5): pii: e005354.
|
[7] |
Morys JM, Bellwon J, Hofer S, et al. Quality of life in patients with coronary heart disease after myocardial infarction and with ischemic heart failure[J]. Arch Med Sci, 2016, 12 (2): 326-333.
|
[8] |
El Khoudary SR. Gaps, limitations and new insights o-n endogenous estrogen and follicle stimulating hormone as related to risk of cardiovascular disease in women traversing the menopause: a narrative review[J]. Maturitas, 2017 (104): 44-53.
|
[9] |
Buket BG, Mahmut G, Ibrahim T, et al. The effect of perimenopausal estrogen levels on depression and anxiety: a pilot study[J]. Eur Res J, 2015, 1 (1): 8-14.
|
[10] |
Suls J. Toxic affect: are anger, anxiety, and depression independent risk factors for cardiovascular disease?[J]. Emotion Review, 2017, 10 (1): 6-17.
|
[11] |
Geiser F, Urbach AS, Harbrecht U, et al. Anxiety and depression in patients three months after myocardial infarction: association with markers of coagulation and the relevance of age[J]. J Psychosom Res, 2017 (99): 162-168.
|
[12] |
Bertelsen JB, Refsgaard J, Kanstrup H, et al. Self-reported mental health status in patients with acute coronary syndrome: a strong predictor of readmission, of subsequent anxiety and depression and of poor risk factor modification?[J]. J Card Pulm Rehabil, 2017, 1 (2): 113.
|
[13] |
Hargraves D, White C, Frederick R, et al. Implement-ing SBIRT (screening, brief intervention and referral to treatment) in primary care: lessons learned from a multi-practice evaluation portfolio[J]. Public Health Rev, 2017 (38): 31.
|
[14] |
Mikkola TS, Tuomikoski P, Lyytinen H, et al. Estrad-iol-based postmenopausal hormone therapy and risk of cardiovascular and all-cause mortality[J]. Menopause, 2015, 22 (9): 976-983.
|
[15] |
Marjoribanks J, Farquhar CM, Roberts H, et al. Coch-rane corner: long-term hormone therapy for perimenopausal and postmenopausal women[J]. Heart, 2018, 104 (2): 93-95.
|
[16] |
Yang Z, Hu Y, Zhang J, et al. Estradiol therapy and breast cancer risk in perimenopausal and postmenopausal women: a systematic review and meta-analysis[J]. Gynecol Endocrinol, 2017, 33 (2): 87-92.
|